To further evaluate the effect of MSC/GM-CSF plus Dox in vivo, an HCC murine model was generated by inoculation of Hepa129 cells, and when the tumours reached ~60 mm3, the mice were treated with Dox (5 mg/kg) to induce ICD and DAMP release. This evidence concerns the gene CSF2 and hepatocellular carcinoma.